Ordering
Available Variants10 g
CHJ.13643-10g
Price
€104.80
Available – Dispatch in 14 days
50 g
CHJ.13643-50g
Price
€360.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 g | CHJ.13643-10g | €104.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 g | CHJ.13643-50g | €360.80 |
crystallized, ≥98.0% (dried material, NT)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H24N2O2 |
|---|---|
| CAS Number | 56-54-2 |
| Molecular Weight | 324.42 |
| UNSPSC Code | 12352103 |
| NACRES | NA.22 |
| PubChem Substance ID | 57647992 |
| EC Number | 200-279-0 |
| Beilstein/REAXYS Number | 91866 |
| MDL number | MFCD00135581 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H301,H317 |
| pcodes | P261 - P264 - P272 - P280 - P301 + P310 - P302 + P352 |
| Hazard Classifications | Acute Tox. 3 Oral - Skin Sens. 1 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 1 |
| ppe | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
Quinidine, with a chemical formula of C20H24N2O2 and a CAS number of 56-54-2, is a class I anti-arrhythmic medication that functions by blocking sodium channels in the heart, thereby reducing the rate of cardiac contractions. It is primarily used to treat various types of arrhythmias, including atrial fibrillation and ventricular tachycardia. Quinidine is also known to have a negative inotropic effect, which can decrease the contractility of the heart muscle. The medication is often administered orally, with its absorption and distribution influenced by factors such as gastric pH and plasma protein binding. Quinidines therapeutic effects are dose-dependent, and its use requires careful monitoring due to potential side effects, including gastrointestinal disturbances, cardiac toxicity, and immune system reactions. As with other anti-arrhythmic medications, quinidines efficacy and safety profile must be carefully evaluated in each patient.
